The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Amarin Corporation plc(NASDAQ:AMRN) 
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing t...
Website: http://www.amarincorp.com
Founded: 1989
Full Time Employees: 965
Sector: Healthcare
Industry: Biotechnology
Amarin plc Days Payable Outstanding ttm (DPO)
Amarin plc Days Receivable Outstanding ttm (DSO)
Amarin plc Days Inventory Outstanding ttm (DIO)
Amarin plc Op Cashflow Per Share ttm
Amarin plc Free Cashflow Per Share ttm
Amarin plc Cash Per Share ttm
Amarin plc P/S ratio ttm
Amarin plc (GAAP) P/E ratio ttm
Amarin plc P/B ratio ttm
No extra charts and metrics for this ticker.